| 产品描述: | VU591 hydrochloride 是一种强效的、选择性的肾外髓钾通道 (ROMK 或Kir1.1) 的抑制剂,其 IC50 值为 0.24 μM。VU591 hydrochloride 和它的等效物 HY-108585A 可用于神经领域的研究。 |
| 靶点: |
IC50: 0.24 μM (ROMK). |
| 体外研究: |
VU591 hydrochloride is a selective ROMK inhibitor and a ROMK channel pore blocker. VU591 can bind serum protein and has high metabolic stability. |
| 体内研究: |
VU591 hydrochloride (i.c.v.; 1.842 μg) significantly decreases the immobile time in TST. |
| 参考文献: |
1. Bhave G, et al. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel. Mol Pharmacol. 2011 Jan;79(1):42-50.
2. Masayoshi Okada, et al. Antidepressive effect of an inward rectifier K+ channel blocker peptide, tertiapin-RQ. PLoS One. 2020 Nov 13;15(11):e0233815. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.471 ml |
12.353 ml |
24.706 ml |
| 5 mM |
0.494 ml |
2.471 ml |
4.941 ml |
| 10 mM |
0.247 ml |
1.235 ml |
2.471 ml |
| 50 mM |
0.049 ml |
0.247 ml |
0.494 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |